Navigation Links
Medical Teachers Retirement Age Increased

The Punjab government Thursday decided to enhance retirement age for government medical teachers to 60 years.//

The decision was taken at a meeting of the Punjab cabinet here.

The retirement age has been increased for medical, dental and ayurvedic teachers.

The government also announced that vacant posts of medical teachers would be filled with re-employment of teachers who retired in 2006-07.

The decision has been taken to save medical colleges in Punjab from disaffiliation from the Medical Council of India (MCI).

In some medical colleges there was an acute shortage of medical teachers in various disciplines.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Indian Nationals with Foreign Medical Degrees can now practice in India
2. Meditation Works Medically
3. Sleep Disorders Could Indicate Other Medical Problems
4. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
5. Hypnosis Found To Reduce Stress In Children During Medical Procedures
6. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
7. Ayurvedic Therapies Cashing In On Medical Tourism
8. Prevention And Timely Medical Care Can Help With Bug Bites
9. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
10. Grant of $7 million for Orissa Medical College from Japan
11. Indian Hospitals – A Destination For Quality Medical Care
Post Your Comments:
(Date:12/1/2008)... emission mammography (PEM), a new technique for i...t density or a woman,s hormonal status, two factor...aphy and MRI at detecting cancer. Results will be ...logical Society of North America (RSNA). , "The ... be adversely affected by breast density, hormone ...
(Date:12/1/2008)...Call/ -- The Ensign Group, Inc.,(Nasdaq: ENSG )...ation Center in,Pocatello, Idaho has successfully...caid Services, Special Focus program. , (Lo.../LATH168LOGO ) , A clinical team led by Lau...& Rehabilitation Center, completed the complex...
(Date:12/1/2008)...ial Sloan-Kettering Cancer Center, New York, have ...n of genes for therapeutic purposes, and used this..., Small, noncoding RNA molecules known as miRNAs...n. In the study, the miRNA miR-181a was harnessed ...nown as T cells at different stages of their devel...
(Date:12/1/2008)...-- ViroPharma Incorporated,(Nasdaq: VPHM ) toda...tal,Biologics License Application (sBLA) to the U...e(TM) C1 Inhibitor (human) as a treatment for acut... The sBLA is based on a re-analysis and resubmiss...t study of Cinryze and interim data from an ongoin...
Breaking Medicine News(10 mins):Health News:New mammography technology effective in detecting breast cancer 2Health News:The Ensign Group Successfully Graduates Second Nursing Home From CMS Special Focus Program 2Health News:The Ensign Group Successfully Graduates Second Nursing Home From CMS Special Focus Program 3Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 2Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 3Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 4Health News:ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema 5
...vior in her daughter, who helped raise the life-sa... could be made available for her to fight debilita... had refused the cancer drug to Mrs. Morgan, of Wh...nd all of ten, wrote to Shropshire MP Owen Paterso...
...ng noted that fewer Americans are eating 'risky' f...icans consume each day are becoming far safer now ...n food borne illness, released at the Internationa...seases in Atlanta, led researchers to conclude tha...
...shedpur have blamed the administration for the pro... the editor of the Journal of Indian Medical Assoc...f the Indian Medical Association, Ajay Kumar Singh... of violence against doctors is because of the gov...
...ee that the woman who sued them for ?250,000 over ... eventually gave birth to her daughter Jayde and s...sked for maintenance for the girl. However, the ... then aged 16 was given no guarantees that the abo...
Other Medicine News:Health News:Americans Avoiding Risky Foods 2
(Date:11/27/2008)...New study finds the majority of acute lymphoblasti... present at the time of diagnosis , , MEMPH...ntists at St. Jude Children,s Research Hospital ha...ancer cells of children with acute lymphoblastic l...rs a pathway to designing treatments for ALL relap...
(Date:11/25/2008)...LOUISVILLE, Ky., Nov. 25 /PRNewswire-USNewswire/ -...d surgeons performed the fifth U.S. hand transplan...ky, at Louisville,s Jewish Hospital Hand Care Cent...re began around noon and was completed shortly aft...o: http://www.newscom.com/cgi-bin/prnh/20081125/...
(Date:11/25/2008)...200 Patients Enrolled in Clinical Trial to Assess ...d of Care Therapies for Unresectable Hepatocellula...RNewswire/ -- Light Sciences Oncology, Inc. (LSO) ...global Phase 3 clinical trial of Light Infusion Th...le hepatocellular carcinoma (HCC), also known as h...
(Date:11/24/2008)...november is Pancreatic Cancer Awareness Month , ...wire/ -- The American Society for Gastrointestina...n Network are teaming up this November to raise aw...s about the disease and the resources that are ava...he fourth leading cause of cancer deaths in the U....
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 1Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 2Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 3Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 4Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 5Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 6Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 7Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 8Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 9Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 10Care Investment Trust Inc Announces Fourth Quarter and Partial Year 2007 Results 13986 11Brookdale to Present at Citi Small 26 Mid Cap Conference on March 17 13982 1Mentice AB Announces Leadership Changes Within Its Worldwide Operations 3844 1Mentice AB Announces Leadership Changes Within Its Worldwide Operations 3844 2LifeMasters Strengthens Capital Structure with 2415 Million in Funding from Existing Investors 13978 1LifeMasters Strengthens Capital Structure with 2415 Million in Funding from Existing Investors 13978 2LifeMasters Strengthens Capital Structure with 2415 Million in Funding from Existing Investors 13978 3
...nite to Help Educate on Good,Diabetes Management a...Problems, SEATTLE, April 10, 2007 /PRNewswire/ -- ...ce and cost of type 2 diabetes,complications shows...percent) with type 2 diabetes have at least one of...ated with the disease, and,that these health probl...
...cal utilization management,programs, ST. PAUL, Min...t,manager Prime Therapeutics (Prime) today announc...rattera(R) (atomoxetine) for treating,attention de...he,study found that children who start on Stratter...py than children who started on,stimulants. Due to...
Other Medicine Technology:First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 2First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 3First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 4First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 5First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 6First-of-its-Kind National Report Reveals Estimated High Prevalence,and Heavy Cost of Type 2 Diabetes Complications in America 7Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 2Study Shows Children With ADHD Who Start on Strattera are More,Likely to Change Therapies 3
The Advanta™ PTFE facial implant is an expanded porous polytetrafluoroethylene,material that is intended for augmentation or repair of the soft tissues of the facial,area. This product is avail
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an
The IEC CL40 and FL40 Centrifuge Series from Thermo Electron combines power, safety and versatility to increase your productivity in the lab. Available with a broad array of rotors and accessories fo
The IEC CL30 Series from Thermo delivers maximum convenience and exceptional value for your low-speed clinical applications. With its unique AUTO-LOCK rotor exchange system, user-friendly controls, a
Medicine Products: